
Cisema’s Stefanie Fasshauer shared insights into recent NMPA reforms, drug registration, compliance requirements, and emerging trends shaping China’s pharmaceutical landscape.

Watch Cisema’s webinar on accessing China’s Greater Bay Area via Hong Kong listing. Learn about GBA pathway approvals, Hong Kong drug registration, and medical device market entry.
And discover how we can support you in getting your products certified for China.